What is he best known for?
The fields of study Stanley M. Crain is best known for:
- Gene
- Central nervous system
- Enzyme
While working in this field, Stanley M. Crain studies both Biochemistry and Gene.
He performs multidisciplinary studies into Gene and Biochemistry in his work.
As part of his studies on Neuroscience, Stanley M. Crain often connects relevant subjects like Dorsal root ganglion.
He frequently studies issues relating to Neuroscience and Dorsal root ganglion.
Receptor is often connected to Nociception in his work.
Stanley M. Crain performs multidisciplinary studies into Nociception and Morphine in his work.
Stanley M. Crain integrates Morphine with Analgesic in his study.
His study deals with a combination of Analgesic and Opioid receptor.
By researching both Opioid receptor and Opioid antagonist, Stanley M. Crain produces research that crosses academic boundaries.
His most cited work include:
- A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function (495 citations)
- Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons (312 citations)
- Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability (277 citations)
What are the main themes of his work throughout his whole career to date
Explant culture and Neurite are the main topics of his In vitro study.
His study ties his expertise on In vitro together with the subject of Neurite.
His research on Opioid is centered around (+)-Naloxone, Opioid receptor and Naltrexone.
His (+)-Naloxone study frequently links to adjacent areas such as Internal medicine.
Many of his studies involve connections with topics such as Nociception and Internal medicine.
In his works, Stanley M. Crain conducts interdisciplinary research on Nociception and Opioid.
Naltrexone is closely attributed to Receptor in his study.
His study ties his expertise on Opioid receptor together with the subject of Receptor.
In his papers, he integrates diverse fields, such as Neuroscience and Cell biology.
Stanley M. Crain most often published in these fields:
- Neuroscience (76.92%)
- Biochemistry (59.34%)
- Receptor (50.55%)
What were the highlights of his more recent work (between 2001-2008)?
- Hyperalgesia (75.00%)
- Internal medicine (75.00%)
- Pharmacology (75.00%)
In recent works Stanley M. Crain was focusing on the following fields of study:
His study on Media studies is often connected to Ophthalmology and Library science as part of broader study in Columbia university.
His Media studies study frequently draws connections to other fields, such as Columbia university.
In his research, he undertakes multidisciplinary study on Hyperalgesia and Nociception.
Stanley M. Crain performs multidisciplinary study in the fields of Nociception and Morphine via his papers.
Stanley M. Crain performs integrative study on Morphine and Hyperalgesia.
His research is interdisciplinary, bridging the disciplines of Inhibitory postsynaptic potential and Internal medicine.
His research on Inhibitory postsynaptic potential often connects related topics like Endocrinology.
His research on Endocrinology frequently links to adjacent areas such as Excitatory postsynaptic potential.
In most of his Excitatory postsynaptic potential studies, his work intersects topics such as Biochemistry.
Between 2001 and 2008, his most popular works were:
- Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice (55 citations)
- SOME CYTOLOGIC EFFECTS OF SALIVARY NERVE-GROWTH FACTOR ON TISSUE CULTURES OF PERIPHERAL GANGLIA (42 citations)
- Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice (15 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
